Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

52.200
+3.6007.41%
Volume:60.11M
Turnover:3.06B
Market Cap:216.37B
PE:38.54
High:52.450
Open:48.600
Low:48.120
Close:48.600
52wk High:52.450
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:1.25
T/O Rate:1.45%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.354
ROE:11.64%
ROA:6.88%
PB:3.92
PE(LYR):38.54
PS:8.51

Loading ...

Movement Alert|WUXI BIO Falls 3.33% in Regular Trading, CXO Sector Pullback and Pre-Earnings Profit-Taking Weigh on Shares

Market Focus
·
Aug 24

TOT Biopharm FY26 H1 Net Loss Swings to RMB 59 Million; Revenue Drops 49.7% to RMB 246 Million

Reuters
·
Aug 21

Wuxi Biologics (Cayman) Stock Rallies 2.7% in Hong Kong

Dow Jones
·
Aug 21

Movement Alert|WUXI BIO Rises 6.16% in Regular Trading, Interim Results Review Imminent Amid CXO Sector Rally

Market Focus
·
Aug 20

Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing

Stock News
·
Aug 20

Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong

Dow Jones
·
Aug 19

Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut

Stock News
·
Aug 18

WuXi Biologics Wins BioPharma APAC Spot on 2026 Sustainable Biopharma List

Reuters
·
Aug 18

WuXi XDC Secures GMP Release for BCM3 Bioconjugate Production Line in Singapore

Reuters
·
Aug 18

HK Movers | Pharma Stocks Rally With Genscript Biotech up 6%, WuXi Biologics up 5%

Tiger Newspress
·
Aug 18

Movement Alert|WUXI BIO Rises 3.38% in Regular Trading, CXO Sector Momentum Sustained as Interim Results Approach

Market Focus
·
Aug 18

Earning Preview: WUXI BIO this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
Aug 18

Wuxi Biologics (Cayman) Stock Rises 2.3% in Hong Kong

Dow Jones
·
Aug 17

WuXi Biologics Agrees to Sell 51.1% Stake in Bestchrom

Reuters
·
Aug 17

HK Movers | Pharma Stocks Gain With HUTCHMED up 8%, JOINN up 6%

Tiger Newspress
·
Aug 17

Movement Alert|WUXI BIO Rises 3.5% in Regular Trading, CXO Sector Upswing and Strategic Asset Disposal Boost Sentiment

Market Focus
·
Aug 17

Everest Medicines Appoints Yue Wang as Non-Executive Director

Reuters
·
Aug 14

Wuxi Biologics (Cayman) Stock Sheds 1.3% in Hong Kong

Dow Jones
·
Aug 14

Akari Net Loss Widens to $4.81 Million in Q2 FY26; Operating Loss Rises to $4.6 Million

Reuters
·
Aug 14

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

Stock News
·
Aug 13